Mid-term outcome of endovascular revascularization for chronic mesenteric ischaemia.
Dias, Nuno LU
; Acosta, Stefan
LU
; Resch, Tim
LU
; Sonesson, Björn
LU
; Alhadad, Alaa
LU
; Malina, Martin
LU
and Ivancev, Krassi
LU
(2010)
In British Journal of Surgery
97.
p.195-201
- Abstract
- BACKGROUND:: This study aimed to assess mid-term outcome after endovascular revascularization of chronic occlusive mesenteric ischaemia (CMI) and to identify possible predictors of mortality. METHODS:: Consecutive patients undergoing primary elective stenting for CMI between 1995 and 2007 were registered prospectively in a database. Patients with acute ischaemia were excluded. Retrospective case-note review and data analysis were performed. RESULTS:: Forty-three patients (10 men) were treated for stable (n = 30) or exacerbated (n = 13) CMI. Their median (interquartile range (i.q.r.)) age was 70 (60-79) years. Revascularization was successful in 47 of 49 vessels. The superior mesenteric artery (SMA), either alone (n = 34) or in combination... (More)
- BACKGROUND:: This study aimed to assess mid-term outcome after endovascular revascularization of chronic occlusive mesenteric ischaemia (CMI) and to identify possible predictors of mortality. METHODS:: Consecutive patients undergoing primary elective stenting for CMI between 1995 and 2007 were registered prospectively in a database. Patients with acute ischaemia were excluded. Retrospective case-note review and data analysis were performed. RESULTS:: Forty-three patients (10 men) were treated for stable (n = 30) or exacerbated (n = 13) CMI. Their median (interquartile range (i.q.r.)) age was 70 (60-79) years. Revascularization was successful in 47 of 49 vessels. The superior mesenteric artery (SMA), either alone (n = 34) or in combination with the coeliac trunk (n = 6), was the predominant target vessel. No patient died within 30 days. Median follow-up was 43 (i.q.r. 25-63) months and the estimated (s.e.) 3-year overall survival rate was 76(7) per cent. Two patients died from distal SMA occlusive disease and intestinal infarction after 6 and 18 months respectively. Previous stroke (P = 0.016), male sex (P = 0.057) and age (P = 0.066) were associated with mid-term mortality on univariable, but not multivariable analysis. Reintervention was needed in 14 patients, achieving a 3-year cumulative rate of freedom from recurrent symptoms of 88(5) per cent. CONCLUSION:: Endovascular treatment provided high early and mid-term survival rates in this series of patients with CMI, with low complication rates. Copyright (c) 2009 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1523284
- author
- Dias, Nuno
LU
; Acosta, Stefan
LU
; Resch, Tim
LU
; Sonesson, Björn
LU
; Alhadad, Alaa
LU
; Malina, Martin
LU
and Ivancev, Krassi
LU
- organization
- publishing date
- 2010
- type
- Contribution to journal
- publication status
- published
- subject
- in
- British Journal of Surgery
- volume
- 97
- pages
- 195 - 201
- publisher
- Oxford University Press
- external identifiers
-
- wos:000274098100009
- pmid:20035543
- scopus:74549194474
- pmid:20035543
- ISSN
- 1365-2168
- DOI
- 10.1002/bjs.6819
- language
- English
- LU publication?
- yes
- id
- 5bc76c1f-695a-4136-83c9-73efd6f2eab5 (old id 1523284)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/20035543?dopt=Abstract
- date added to LUP
- 2016-04-04 08:10:21
- date last changed
- 2022-05-16 21:02:47
@article{5bc76c1f-695a-4136-83c9-73efd6f2eab5,
abstract = {{BACKGROUND:: This study aimed to assess mid-term outcome after endovascular revascularization of chronic occlusive mesenteric ischaemia (CMI) and to identify possible predictors of mortality. METHODS:: Consecutive patients undergoing primary elective stenting for CMI between 1995 and 2007 were registered prospectively in a database. Patients with acute ischaemia were excluded. Retrospective case-note review and data analysis were performed. RESULTS:: Forty-three patients (10 men) were treated for stable (n = 30) or exacerbated (n = 13) CMI. Their median (interquartile range (i.q.r.)) age was 70 (60-79) years. Revascularization was successful in 47 of 49 vessels. The superior mesenteric artery (SMA), either alone (n = 34) or in combination with the coeliac trunk (n = 6), was the predominant target vessel. No patient died within 30 days. Median follow-up was 43 (i.q.r. 25-63) months and the estimated (s.e.) 3-year overall survival rate was 76(7) per cent. Two patients died from distal SMA occlusive disease and intestinal infarction after 6 and 18 months respectively. Previous stroke (P = 0.016), male sex (P = 0.057) and age (P = 0.066) were associated with mid-term mortality on univariable, but not multivariable analysis. Reintervention was needed in 14 patients, achieving a 3-year cumulative rate of freedom from recurrent symptoms of 88(5) per cent. CONCLUSION:: Endovascular treatment provided high early and mid-term survival rates in this series of patients with CMI, with low complication rates. Copyright (c) 2009 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.}},
author = {{Dias, Nuno and Acosta, Stefan and Resch, Tim and Sonesson, Björn and Alhadad, Alaa and Malina, Martin and Ivancev, Krassi}},
issn = {{1365-2168}},
language = {{eng}},
pages = {{195--201}},
publisher = {{Oxford University Press}},
series = {{British Journal of Surgery}},
title = {{Mid-term outcome of endovascular revascularization for chronic mesenteric ischaemia.}},
url = {{http://dx.doi.org/10.1002/bjs.6819}},
doi = {{10.1002/bjs.6819}},
volume = {{97}},
year = {{2010}},
}